AMJ Microbiology & Infectious Diseases 4 [Supplement 4] 4. 2026

The treatment options for Clostridioides difficile are changing, with two FDA-approved microbiota products, discontinued therapies, and… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

My interest in macrophage antibacterial defence lies in therapeutically augmenting it through host-directed therapies, as an alternative… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

I grew up in a family of public health practitioners; both my parents were microbiologists, and I am extremely close to them. While I was… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

My journey has been a long one. I am a paediatric immunologist and principal investigator of a PID research laboratory, and this… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.